Swift Cardiovascular, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-24.
Swift Cardiovascular, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 24, 2026. The filing reports $810K sold. Its industry group is Biotechnology. It names Jeffrey Lawson (Executive Officer, Director), Kemal Schankereli (Director), Howard Kelly (Director) (SEC Form D, September 24, 2026).
Swift Cardiovascular, Inc. raised on Sep 24. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Swift Cardiovascular, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Swift Cardiovascular, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Swift Cardiovascular, Inc.
Free to see. No signup.
More on the people and the money behind Swift Cardiovascular, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Swift Cardiovascular, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Swift Cardiovascular, Inc. raises, hires or launches. No email unless you switch it on.
Watch Swift Cardiovascular, Inc. →Get the full cited report on Swift Cardiovascular, Inc.
What the filing shows about Swift Cardiovascular, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Swift Cardiovascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Swift Cardiovascular, Inc.'s address as 110 Swift Avenue, Durham, NC 27705.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Swift Cardiovascular, Inc. See pricing
Swift Cardiovascular, Inc. is a registered filer with the SEC (CIK 2117135) and has filed since 2026-09-24. 1 filing is on record, the latest on 2026-09-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Swift Cardiovascular, Inc.'s Form D of 2026-09-24 names Jeffrey Lawson, Kemal Schankereli, Howard Kelly and 2 more as its officers, directors or promoters.
Its new offerings report $810K sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $810K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Other than the payment of salaries or benefits, contractual consulting fees, expense reimbursement, and the like, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
Jeffrey Lawson is named as Executive Officer and Director on the Form D that Swift Cardiovascular, Inc. filed with the SEC on 24 September 2026, one of 5 people that filing names.
Kemal Schankereli is named as Director on the Form D that Swift Cardiovascular, Inc. filed with the SEC on 24 September 2026, one of 5 people that filing names.
Howard Kelly is named as Director on the Form D that Swift Cardiovascular, Inc. filed with the SEC on 24 September 2026, one of 5 people that filing names.
Richard Murphy is named as Executive Officer on the Form D that Swift Cardiovascular, Inc. filed with the SEC on 24 September 2026, one of 5 people that filing names.
Jospeh Long is named as Executive Officer on the Form D that Swift Cardiovascular, Inc. filed with the SEC on 24 September 2026, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2026-09-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Swift Cardiovascular, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Swift Cardiovascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Swift Cardiovascular, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Swift Cardiovascular, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Swift Cardiovascular, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Swift Cardiovascular, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-09-21 · Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/swift-cardiovascular-inc-form-d-000001